litlas
Log inCreate account

D. Lawrence Wickerham

Active 1983–2019

Also published as
D Lawrence Wickerham · D. LAWRENCE WICKERHAM
69
Papers
51,168
Citations
68
h-index
69
i10-index

Citations

Citations per year for D. Lawrence Wickerham1974: 1 citations1982: 1 citations1984: 4 citations1985: 13 citations1986: 11 citations1987: 11 citations1988: 16 citations1989: 23 citations1990: 24 citations1991: 32 citations1992: 38 citations1993: 37 citations1994: 47 citations1995: 51 citations1996: 64 citations1997: 75 citations1998: 133 citations1999: 208 citations2000: 261 citations2001: 377 citations2002: 301 citations2003: 338 citations2004: 339 citations2005: 436 citations2006: 389 citations2007: 411 citations2008: 433 citations2009: 403 citations2010: 412 citations2011: 380 citations2012: 339 citations2013: 397 citations2014: 323 citations2015: 342 citations2016: 265 citations2017: 251 citations2018: 255 citations2019: 894 citations2020: 882 citations2021: 799 citations2022: 533 citations2023: 387 citations2024: 558 citations2025: 241 citations2026: 14 citations1975–1981: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,573 citing papers, 34.2% of this breakdownUnited Kingdom: 966 citing papers, 7.2% of this breakdownChina: 767 citing papers, 5.7% of this breakdownItaly: 698 citing papers, 5.2% of this breakdownCanada: 624 citing papers, 4.7% of this breakdownGermany: 565 citing papers, 4.2% of this breakdownFrance: 467 citing papers, 3.5% of this breakdownNetherlands: 421 citing papers, 3.1% of this breakdownSpain: 344 citing papers, 2.6% of this breakdownAustralia: 332 citing papers, 2.5% of this breakdownSwitzerland: 310 citing papers, 2.3% of this breakdownBelgium: 290 citing papers, 2.2% of this breakdown
0%34.2%Other 22.6%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology53.9%
  • Medicine39.8%
  • Computer Science1.6%
  • Immunology and Microbiology1%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Mathematics0.5%
  • Other2.6%

Topics

  • Breast Cancer Treatment Studies16.5%
  • Breast Lesions and Carcinomas6.6%
  • HER2/EGFR in Cancer Research5.1%
  • Estrogen and related hormone effects4.3%
  • Breast Implant and Reconstruction3%
  • BRCA gene mutations in cancer2.7%
  • Other61.8%

Coauthors

All papers

Open in search
  1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    Authors: Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz - The Lancet 2014 cited by 4,710

  2. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Authors: Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark - New England Journal of Medicine 2004 cited by 6,358

  3. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Authors: Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2006 cited by 2,577

  4. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

    Authors: Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Carol Redmond, Maureen Kavanah, Walter M. Cronin, Victor G. Vogel, André Robidoux, Nikolay Dimitrov, James N. Atkins, Mary B. Daly, Samuel Wieand, Elizabeth Tan-Chiu, Leslie G. Ford, Norman Wolmark, other National Surgical Adjuvant Breast, Bowel Project Investigators - JNCI Journal of the National Cancer Institute 1998 cited by 5,508

  5. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

    Authors: Bernard Fisher, A Brown, E.P. Mamounas, Sam Wieand, A. Robidoux, Richard G. Margolese, Anatolio B. Cruz, Edwin R. Fisher, D. Lawrence Wickerham, Norman Wolmark, Arthur P. DeCillis, James L. Hoehn, Alan Lees, N V Dimitrov - Journal of Clinical Oncology 1997 cited by 1,809

  6. Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

    Authors: Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, Reena S. Cecchini, Walter M. Cronin, André Robidoux, Therese B. Bevers, Maureen Kavanah, James N. Atkins, Richard G. Margolese, Carolyn D. Runowicz, Joan James, Leslie G. Ford, Norman Wolmark - JNCI Journal of the National Cancer Institute 2005 cited by 1,335

  7. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    Authors: Bernard Fisher, John Bryant, Norman Wolmark, E.P. Mamounas, A Brown, Edwin R. Fisher, D. Lawrence Wickerham, Mirsada Begovič, Arthur P. DeCillis, A Robidoux, Richard G. Margolese, Anatolio B. Cruz, James L. Hoehn, Alan Lees, N V Dimitrov, Harry D. Bear - Journal of Clinical Oncology 1998 cited by 2,192

  8. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

    Authors: Jack Cuzick, Ivana Šestak, Bernardo Bonanni, Joseph P. Costantino, Steve Cummings, Andrea DeCensi, Mitch Dowsett, John Forbes, Leslie G. Ford, Andrea Z. LaCroix, John L. Mershon, Bruce Mitlak, Trevor J. Powles, Umberto Veronesi, Victor G. Vogel, D. Lawrence Wickerham - The Lancet 2013 cited by 486

  9. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

    Authors: Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham, Walter M. Cronin, Reena S. Cecchini, James N. Atkins, Therese B. Bevers, Louis Fehrenbacher, Eduardo R. Pajon, James L. Wade, André Robidoux, Richard G. Margolese, Joan James, Carolyn D. Runowicz, Patricia A. Ganz, Steven E. Reís, Worta McCaskill‐Stevens, Leslie G. Ford, V. Craig Jordan, Norman Wolmark, for the National Surgical Adjuvant Breast and Bowel Project - Cancer Prevention Research 2010 cited by 639

  10. Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27

    Authors: Harry D. Bear, Stewart Anderson, Roy E. Smith, Charles E. Geyer, Eleftherios P. Mamounas, Bernard Fisher, Ann Brown, André Robidoux, Richard G. Margolese, Morton S. Kahlenberg, Soonmyung Paik, Atilla Soran, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2006 cited by 948

  11. Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

    Authors: Eleftherios P. Mamounas, Ann Brown, Stewart Anderson, Roy E. Smith, Thomas B. Julian, Bárbara Miller, Harry D. Bear, Christopher B. Caldwell, Alonzo Walker, Wendy M. Mikkelson, Jay S. Stauffer, André Robidoux, Heather Theoret, Atilla Sovan, Bernard Fisher, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2005 cited by 550

  12. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky, Jong‐Hyeon Jeong, Charles E. Geyer, Priya Rastogi, Louis Fehrenbacher, Mark L. Graham, Stephen Chia, Adam Brufsky, Janice M. Walshe, Gamini S. Soori, Shaker R. Dakhil, Thomas E. Seay, James L. Wade, Edward C. McCarron, Soonmyung Paik, Sandra M. Swain, D. Lawrence Wickerham, Norman Wolmark - The Lancet Oncology 2018 cited by 163

  13. Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

    Authors: Eleftherios P. Mamounas, Stewart Anderson, James J. Dignam, Harry D. Bear, Thomas B. Julian, Charles E. Geyer, Alphonse G. Taghian, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2012 cited by 586

  14. Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

    Authors: B. Fisher, Joseph P. Costantino, Carol Redmond, E R Fisher, D. Lawrence Wickerham, Walter M. Cronin, Other NSABP Contributors - JNCI Journal of the National Cancer Institute 1994 cited by 1,280

  15. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

    Authors: Harry D. Bear, Stewart Anderson, Ann Brown, Roy E. Smith, Eleftherios P. Mamounas, Bernard Fisher, Richard G. Margolese, Heather Theoret, Atilla Soran, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2003 cited by 1,132

  16. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

    Authors: Bernard Fisher, Madeline Bauer, D. Lawrence Wickerham, Carol Redmond, Edwin R. Fisher, Anatolio B. Cruz, Roger S. Foster, Bernard Gardner, Harvey J. Lerner, Richard G. Margolese, R Poisson, Henry R. Shibata, Herbert Volk, OTHER NSABP INVESTIGATORS - Cancer 1983 cited by 1,040

  17. Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

    Authors: D. Craig Allred, Stewart Anderson, Soonmyung Paik, D. Lawrence Wickerham, Irıs D. Nagtegaal, Sandra M. Swain, Elefetherios P. Mamounas, Thomas B. Julian, Charles E. Geyer, Joseph P. Costantino, Stephanie R. Land, Norman Wolmark - Journal of Clinical Oncology 2012 cited by 360

  18. Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

    Authors: Bernard Fisher, John Bryant, James J. Dignam, D. Lawrence Wickerham, Eleftherios P. Mamounas, Edwin R. Fisher, Richard G. Margolese, Lois Nesbitt, Soonmyung Paik, Thomas M. Pisansky, Norman Wolmark - Journal of Clinical Oncology 2002 cited by 696

  19. Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer

    Authors: Patrick G. Gavin, Nan Song, S. Rim Kim, Corey Lipchik, Nicole L. Johnson, Hanna Bandos, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas, Sandra M. Swain, D. Lawrence Wickerham, Charles E. Geyer, Jong‐Hyeon Jeong, Joseph P. Costantino, Norman Wolmark, Soonmyung Paik, Kay L. Pogue-Geile - JAMA Oncology 2016 cited by 113

  20. Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

    Authors: Eleftherios P. Mamounas, John Bryant, Barry C. Lembersky, Louis Fehrenbacher, Scot Sedlacek, Bernard Fisher, D. Lawrence Wickerham, Greg Yothers, Atilla Soran, Norman Wolmark - Journal of Clinical Oncology 2005 cited by 714

  21. Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

    Authors: Eleftherios P. Mamounas, Gong Tang, Bernard Fisher, Soonmyung Paik, Steven Shak, Joseph P. Costantino, Drew Watson, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2010 cited by 653

  22. Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

    Authors: Rim S. Kim, Nan Song, Patrick G. Gavin, Roberto Salgado, Hanna Bandos, Zuzana Kos, Giuseppe Floris, Gert G. G. M. Van den Eynden, Sunil Badve, Sandra Demaria, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas, Sandra M. Swain, D. Lawrence Wickerham, Joseph P. Costantino, Soonmyung Paik, Norman Wolmark, Charles E. Geyer, Peter C. Lucas, Katherine L. Pogue–Geile - JNCI Journal of the National Cancer Institute 2019 cited by 55

  23. Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer

    Authors: Bernard Fisher, Stewart Anderson, Carol Redmond, Norman Wolmark, D. Lawrence Wickerham, Walter M. Cronin - New England Journal of Medicine 1995 cited by 1,468

  24. Real-World Performance of HER2 Testing-National Surgical Adjuvant Breast and Bowel Project Experience

    Authors: Soonmyung Paik, Jennifer Bryant, Elizabeth Tan-Chiu, Edward H. Romond, W. Douglas B. Hiller, K Park, A Brown, Greg Yothers, Stewart Anderson, Roger P. Smith, D. Lawrence Wickerham, Norman Wolmark - JNCI Journal of the National Cancer Institute 2002 cited by 496